AbbVie's Kirsten O'Doherty: Judge people on output, not attendance

December 10, 2018 Latest News BioPharmaDispatch Executive News of the Day 'MyBioPharmaSpace'

This is a preview of subscriber content

Subscribe now to continue reading.

The industry's challenge is to improve the number of women in senior leadership roles, says AbbVie managing director and Medicines Australia board member Kirsten O'Doherty. …

Subscribe now to continue reading.

Latest Video

Two new listings add treatment choices for growth hormone deficiency and people with type 1 diabetes
June 29, 2026 - Latest News
A comment that highlights how complexity is making the challenge more challenging
June 29, 2026 - Latest News
Officials highlight benefits but urge caution in rollout of AI-driven medical scribes
June 29, 2026 - Latest News
When it comes to negotiating with government, trust actions and not words
June 30, 2026 - Latest News
New MSD vaccine listed on national program with expanded eligibility
June 30, 2026 - Latest News

AbbVie's Kirsten O'Doherty: Judge people on output, not attendance

This is a preview of subscriber content

Latest Video

Most Read

Two new listings add treatment choices for growth hormone deficiency and people with type 1 diabetes

A comment that highlights how complexity is making the challenge more challenging

Officials highlight benefits but urge caution in rollout of AI-driven medical scribes

When it comes to negotiating with government, trust actions and not words

New MSD vaccine listed on national program with expanded eligibility

New Stories

The minister is following a tried and tested process, but what is the risk in this new world?

Patient alarm over the potential loss of subsidised access to MS medicines

Significant day marked by negotiation trigger and wholesaler remuneration changes

Protection gap leaves older Australians vulnerable this winter

Pharmacy Guild rejects AMA alarm over broader prescribing powers

Governments backs inhaled RNA therapy with the potential to change the future of chronic lung disease treatment

Major new survey shows patients paying more and waiting longer for medicines

Sign In

AbbVie's Kirsten O'Doherty: Judge people on output, not attendance

This is a preview of subscriber content

Latest Video

Most Read

Two new listings add treatment choices for growth hormone deficiency and people with type 1 diabetes

A comment that highlights how complexity is making the challenge more challenging

Officials highlight benefits but urge caution in rollout of AI-driven medical scribes

When it comes to negotiating with government, trust actions and not words

New MSD vaccine listed on national program with expanded eligibility

Follow Us

New Stories

The minister is following a tried and tested process, but what is the risk in this new world?

Patient alarm over the potential loss of subsidised access to MS medicines

Significant day marked by negotiation trigger and wholesaler remuneration changes

Protection gap leaves older Australians vulnerable this winter

Pharmacy Guild rejects AMA alarm over broader prescribing powers

Governments backs inhaled RNA therapy with the potential to change the future of chronic lung disease treatment

Major new survey shows patients paying more and waiting longer for medicines